Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.

Tony S K Mok; Kwok Chi Lam; Conrad Lee; Li Zhang; Herman Wong; Anthony T C Chan; Winnie Yeo; Anthony P C Yim; Karen Chak; Benny Zee

doi:10.1159/000086992

Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.

NobleID: NI3P52W02R66S41
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CB271F23

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB271F23.svg?ark=w1%2F20260515%2FCB271F23&value=id)](https://nobleid.org/work/w1/20260515/CB271F23)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer.

NobleID: NI3P52W02R66S41
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/CB271F23

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB271F23.svg?ark=w1%2F20260515%2FCB271F23&value=id)](https://nobleid.org/work/w1/20260515/CB271F23)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work